CTT Pharma Submits Proposal for NIH Grant
-
General Hospital actor Randall England dies at 75
-
Argentina Inflation Rises to 2.2% in October Amid Core Price Decline
-
Bunnie XO artwork taken down from Jelly Roll’s Nashville bar
-
London museum removes Russell Brand hair exhibit after rape conviction
-
NRC Approves Construction of Advanced Nuclear Reactors at Texas Petrochemical Site
-
Arlington sentinel rebukes Pete Hegseth entourage for laughter near memorial
-
Yella Beezy sentenced to life for arranging rapper Mo3’s murder
-
Kylie Jenner employee describes closet ordeal and pepper-spray incident
-
Xi Jinping Urges Unity and Reunification at Sun Yat-sen Anniversary
-
Raz B's Son Died of Asphyxia Due to Airway Obstruction
-
Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness
-
Authorities to identify Montauk Mary and five other Long Island cold-case victims
-
Davante Adams injury deepens Los Angeles Rams receiver shortage
-
Barbie sequel negotiations stall over reported $25 million pay packages
-
João Franco’s earlier post draws attention after arrest over fatal Turkey brawl
-
Bath & Body Works launches buy-one-get-one-free candle offer
-
Itlu Arjuna receives U/A certificate ahead of theatrical release
-
Dhananjaya de Silva guides Sri Lanka to 221-4 against Pakistan
-
Niraj Kumar earns Los Angeles Olympic quota with 50m rifle bronze
-
Delhi gold loses Rs 800 while silver falls Rs 5,000
-
India extends micro-credit guarantee plan for five years
-
Madlanga Commission Deadline Extended to 2027 Amid Calls for Structural Justice Reform
-
Pradeep Antony, Smeha Manimegalai portray secret spouses in Mr & Mrs Office
-
Zelenskyy arrives in Dublin for meetings on Ukraine and peace efforts
-
Black Brazilian Musician Freed After Year in Detention Calls for Immigrant Solidarity
-
Woman barred from every Greggs outlet after series of offences
-
Jury hears social-media image helped identify teen in Scarlett Faulkner case
-
Ketchup packets link suspect to break-in at Eddie Rocket’s restaurant
-
American Airlines passenger falls ill and vomits on three travellers
-
Spain's General Strike Links Housing Crisis to Lost Purchasing Power
-
Euro-Area Inflation Reaches 4% as Energy Prices Jump
-
China's Factory Inflation Accelerates While Consumer Demand Stays Weak
-
US Adds 165,000 Jobs as Unemployment Falls to 4.1%
-
Bank of England Raises Interest Rate to 4% as Energy Risks Intensify
-
Energy Costs Push OECD Inflation Up to 4.5%
-
OPEC Says Oil Output Is Near Prewar Levels Despite Shipping Disruptions
-
China's Trade Surplus Passes $1 Trillion as Technology Exports Surge
-
China's Singles' Day Exposes Persistent Consumer Caution
-
US Inflation Broadens as Fed Officials Consider Faster Rate Hikes
-
Irish police prepare for further hoax bomb threats after hundreds of schools targeted
-
Korea, Singapore and New Zealand Advance Green Trade Pact Talks
-
RBA Inflation Target Origins: Why Australia Chose a Range Over Zero
-
Ireland and Ukraine consider drone cooperation memorandum after Dublin talks
-
Sister recounts fatal machete attack as Irish murder trial continues
-
Georgia refrigeration company sues EPA after five-year HFC reprieve
-
NEET’s Merit Promise Erodes as Cost and Time Barriers Rise for Medical Aspirants
-
Lakers Defeat Bucks 123-112 Amid Injury Concerns for Dončić and Reaves
-
HoloCoder technology promises brighter smartphone images and 3D depth data
-
The Good Daughter Streaming Guide: Release Date, Platforms, and Access
-
EU proposes broad consumer safeguards for apps, subscriptions and ticketing
CTT Pharma Submits Proposal for NIH Grant
TAMPA, FL / ACCESS Newswire / January 30, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) has submitted a grant to the National Institutes of Health (NIH) that will aid in further research and commercialization. This grant is being submitted in addition to the Johns Hopkins University grant for clinical trials and this opportunity was suggested to CTT as a grant that would allow for further research and testing.
The CEO of CTT Pharma Ryan Khouri stated, "Approval of this grant will allow for further research that ultimately would lead to commercialization of our dissolvable nicotine strips". This grant opportunity was brought to the attention of Mr. Khouri after he attended and presented at the FDA/NIH hearing for Advancing Smoking Cessation Technology. Mr. Khouri stated that CTT Pharma's partnership with Johns Hopkins University is a main priority to fund and develop CTT's technology as a smoking cessation product, however, additional funding and relationships that can be established with the NIH to help achieve that goal are being pursued. Mr. Khouri looks forward to working with the NIH and FDA in the future and believes CTT can develop products that effectively increase smoking cessation with the resultant reduction of the risk of heart disease, stroke, and various cancers. CTT anticipates a decision made by the NIH in April 2025 and will inform shareholders accordingly.
About CTT Pharmaceuticals Holdings, Inc.
CTT has patented technology in The United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but are not limited to Nicotine, Vitamins, and Pharmaceuticals. CTT believes that there is a need for our technology in many industries, which includes a smoke-free nicotine strip that can be used as a smoking cessation product and deliver drugs that can help with pain management and anxiety. CTT Pharma incorporates micelle technology into its drug delivery. These strips would dissolve quickly, deliver low dose options and offer better bioavailability.
Investor Relations - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
J.Gomez--AT